Granulocyte-macrophage colony-stimulating factor (GM-CSF) is a hematopoietic growth factor that has been shown t o support cell proliferation in murine fibroblasts engineered to stably express both chains of the human GM-CSF receptor (NIH-GMRI. Because the proto-oncogene c-fos is believed t o provide a link between short-term signals elicited at the membrane and long-term cellular response, we chose t o study the mechanism of GM-CSF-dependent cell regulation using e-fos promoter activity as a molecular marker in both NIH-GMR transfectants and in the CD34+ cell line TF-1. The importance of c-fos and related AP-1 activity in GM-CSF signalling was suggested by a tight correlation between GM-CSF-dependent activation of the c-fos promoter and cell proliferation and by the inhibitory effect of a trans-dominant c-fos mutant on cell growth. To evaluate the contribution of the serum response factor (SRF) associated with the ternary complex factor (TCF) and of STAT proteins t o c-fos promoter HE HEMATOPOIETIC growth factor granulocyte-T macrophage colony-stimulating factor (GM-CSF) stimulates the proliferation of hematopoietic cells and vascular endothelial cells.' In addition, GM-CSF has been shown to suppress apoptosis in hematopoietic to enhance the oxidative burst in neutrophils, and to increase phagocytic activity in macrophages/monocytes,' indicating that it is a multifunctional growth factor. Gene cloning indicates that the receptor for human GM-CSF (GMR) consists of two chains: as and Pc,"' both of which are members of a large superfamily of cytokine receptors with conserved structural features in the extracellular and intracellular domains.',' The latter typically lacks intrinsic enzymatic activities, indicating the requirement for association of the receptor with cytoplasmic proteins that can function as effectors. For 0006-4971/96/8808-0020$3.00/0 activation in response t o GM-CSF, the SRF binding site (SRE) and/or the STAT binding site (SIE) were inactivated. In serum-free medium, both SRE and SIE are essential t o c-fos promoter activation by GM-CSF in NIH-GMR transfectants and in TF-1 cells. No response t o GM-CSF was observed when both sites were mutated. The nature of the STAT family member was further investigated by Western blots and DNA retardation assays using an SIE probe. Our data indicate that GM-CSF induced DNA binding of both STAT1 and STAT3 in NIH-GMR and mainly of STAT3 in TF-1 cells. STAT5 tyrosine phosphorylation was also observed in TF-1 cells. Finally, expression of a dominant negative MAPK mutant, ERK192A, resulted in a decrease of both SRE-and SIE-dependent activation of c-fos promoter by GM-CSF, suggesting that STAT1/3 are regulated not only by tyrosine kinases, but also partially by MAPK.
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GM-CSF, the ligand-receptor interaction is species specific, whereas postreceptor events may be conserved. In fact, it has been shown that expression of the two chains of the human GMR in mouse fibroblasts results in signal transduction,"' morphologic transformation,".I2 and cell proliferation. I3 Ligand-induced activation of GMR leads to c-fos transcription, a proto-oncogene that has been shown to integrate signalling networks that link membrane receptors to nuclear function^.'",'^." The transcription of c-fos is regulated by multiple response elements present within a stretch of 300 bp immediately upstream of the transcription initiation site. These include the sis-inducible element (SIE), a target of STAT (signal transducer and activator of transcription) proteins and the serum response element (SRE) that, together with adjacent sequences, serves as a site of assembly for several proteins, the serum response factor (SRF) and ternary complex factor (p62TCFElk-1).I6 Extracellular signals such as epidermal growth factor (EGF) and nerve growth factor (NGF) have been shown to activate MAP kinase (MAPK; p42ERK-2 and p44ERK-l), resulting in TCFElk-1 phosphorylation and, thereby, c-fos induction." SRE is sufficient to confer serum inducibility to the c-fos promoter, I' whereas the contribution of SIE in this assay appears to be minimal. The importance of SIE in c-fos promoter activity was later shown by platelet-derived growth factor (PDGF) induction. 19. 20 In contrast to SRE, SIE binding is not constitutive and is induced by STAT tyrosine phosphorylation and translocation from the membrane to the nucleus, thereby providing an immediate response to extracellular signal^.'^.^' In non-tyrosine kinase receptors such as GMR, STAT phosphorylation may be mediated by cytoplasmic tyrosine kinases that have been shown to associate with the receptor, eg, Jak-2, Lyn, or Yes.2z~z' The STAT family of transcription factors includes at least six members. GM-CSF has been shown to activate STAT5 and not STATU3 in the murine pro-B -cell line, BaF3, engineered to express human GMR.24 However, recent evidence suggests that GMR activates STAT1 and 3 in neutrophils." For personal use only. on October 27, 2017. by guest www.bloodjournal.org From
GMR SIGNALLING IN C-FOS TRANSCRIPTION 2907
Previous data from our laboratory and elsewhere indicate that the blast cells of acute myeloblastic leukemia (AML) produce a number of growth factors that include interleukinlp (IL-1p) and GM-CSF, which contribute to paracrhe and autocrine growth s t i m~l a t i o n .~~-~~ Interestingly, STAT-related factors are shown to be constitutively activated in these cells,3' possibly as a consequence of endogenous growth factor production or as a result of constitutively activated Jak kinases. Indeed, a gain of function mutation in the Drosophila homolog of mammalian Jak kinases, hop Tum-1, was shown to cause lymph gland hypertrophy and hematologic Together, these observations suggest that the Jak-STAT pathway may be frequently activated in hyperproliferative cells.
A number of reports indicate that GMR increases Rasdependent nucleotide exchange, Raf-1 activation, and MAPKERK tyrosine phosphorylati~n,'~,'~~~~ but the possibility of pathway cross-talk, as shown for IL-6,34 interferon and EGF36 has not been addressed. Thus, it is likely that ERK could regulate early response genes not only by activating TCFElk-1, but also through modulation of STAT function.
The present study was designed to investigate the biologic relevance of both the JAWSTAT and Ras signalling pathways in response to GM-CSF, using c-fos promoter activity as a molecular marker. Two model systems were chosen.
NIH-3T3 transfectants expressing both a and p chains of GMR were used for initial studies, because these were previously shown to respond to GM-CSF. Observations using NIH-GMR were then extended to the CD34+ cell line TF-1,37 which was selected as a model system because the cells express functional cell surface receptors for GM-CSF, IL-3, Steel factor (SF), and erythropoietin (Epo) and have retained a normal requirement for hematopoietic growth factors for survival in culture.38 The nature and significance of STAT activation was investigated through site-directed mutagenesis of SIE in the c-fos promoter and through the study of STAT tyrosine phosphorylation and DNA binding activity. Finally, the role of MAPK in regulating the SRF and STAT pathways was directly addressed using a dominant negative ERK192A.
MATERIALS AND METHODS

Cells.
The mouse fibroblast cell line NIH-3T3 and the NIH GMR transfectants were subcultured three times weekly in Iscove's modified Dulbecco's medium (IMDM; GIBCO, Grand Island, NY) supplemented with 10% fetal calf serum (FCS; GIBCO). The TF-I cell line" was subcultured three times weekly in IMDM supplemented with 10% FCS and 200 pmol/L recombinant GM-CSF. Cell cultures were maintained at 37°C in a fully humidified incubator containing 5% CO,. Where indicated, cells were maintained in serum-free medium supplemented with 1% bovine serum albumin (BSA; Sigma, St Louis, MO) and 180 pg/mL iron saturated transfemn (Tf; Calbiochem, La Jolla, CA), as described previously.28
The GMR cDNA was cloned in the expression vector pME18S? The cDNA for pc (KH97) was cloned in the same vector, but without the neomycin-selectable gene. Both were kindly provided by Dr Toshio Kitamura (DNAX, Palo Alto, CA). The catalytically inactive ERK-1 mutant was constructed by changing threonine 192 to alanine in hamster Erk-1 c D N A~~ using the altered sites
Plasmids.
mutagenesis system (Promega, Madison, WI). The mutant cDNA was subcloned into the eukaryotic expression vector pRC-CMV (Invitrogen, San Diego, CA) to create the plasmid pCMV-HEIT192A. Wild-type or mutated versions of the mouse c-fos promoter were excised by HindIII and Sma I digestions of vectors p301-356wt. p301-356pm6, or p301-356pm1240,41 and cloned into the HindIIISma I sites of the promoterless P X P~ luciferase reporter vector.42 The double mutant fos promoter containing mutations in both SIE and SRE was generated by polymerase chain reaction (PCR) using the mutated SRE fos promoter cloned in the pXP2 vector as a template. Oligonucleotides used were 5'-atgtaaagcttgggcagaatccctccctcctttaca-3' (mSIE) and 5'-ttggcgtcttccattttacc-3' (pXp2-luciferase sequence). The PCR fragment was digested by HindIII-Sma I and inserted in the same sites of the pXP2 vector. RSV-l~ciferase~~ and RSV-GH4 reporter plasmids were used as controls in transient transfections. The pBABEAfos (139-145) construct (kindly provided by Dr P. Jolicoeur, Clinical Research Institute of Montreal, Montreal, Quebec, Canada) was generated by cloning rat c-fos (139-145) cDNA4' into the EcoRI site of the pBABE-puro vector, as described!6
Stable transfection of the genes encoding the a and pC chains of GMR in NIH-3T3 cells. The GMRa cDNA and KH97 were cotransfected by the calcium phosphate method in NIH-3T3 at a ratio of 1: 10, respectively. Briefly, 1 day before transfection, 200,000 cells were seeded in a 60-mm tissue culture dish. On the day of transfection, 400 pL of DNA-Ca3 (PO,), precipitate containing 12 pg of DNA was added to the culture and incubated for 6 hours. Cells were then washed and fed with culture medium. Two days after transfection, the cultures were expanded 1:lO and G418 was added at a concentration of 500 pg/mL. After 14 days in selective medium, independent clones were picked, expanded, and tested for binding. Expression of both transgenes were verified on Northern blots and through cross-linking studies with '251-GM-CSF (data not shown). Binding studies with 1251-GM-CSF were performed on these transfectants as described previou~ly.~' Computer analysis of binding data using the program ALLFIT,* showed the presence of two GM-CSF binding sites; one of high (40 to 100 pmol/L) and the other of low affinity (1 to 19 nmol/L) in all clones.
Retroviral infections. Transfection of the pBABE-puro or pBABE-Afos(139-145) vectors in BOSC 23 cells were performed as de~cribed.4~ Retroviruses were collected 48 hours after transfection and filtered through a 22-pm Millipore filter. Retroviral infections were performed 24 hours after seeding 2 x lo5 NIH-GMR cells on 35-mm petri dishes. Cells were infected with 200 pL of viral suspension (10' pfu/mL) containing 8 pglmL polybrene at 37°C. Cultures were agitated periodically and fed after 2 hours with 2 mL IMDM 10% FCS. Two days after infection, cells were incubated in the presence or absence of 800 pmol/L GM-CSF in serumfree medium containing 1 ' YO BSA, 180 pg/mL iron-saturated Tf, and 10 pg/mL puromycin (Sigma) for selection. Cells were passaged every 2 days until 6 days after selection, when cells were counted or submitted to thymidine incorporation assay.
Evaluation of cell proliferation through membrane jiltration of Wild-type or mutated versions of the fos reporter constructs were transiently transfected in NIH-GMR by the calcium-phosphate method or in TF-I cells by electroporation. NIH-GMR cells were seeded at a concentration of 2.5 X 10' in 60-mm culture dishes. Cells were transfected with 400 pL of Ca,(PO,), precipitate containing 6 to 10 pg of plasmid DNA. After 16 hours, the precipitate was removed and the cells were washed once with PBS. Cells were then incubated for 24 hours in serum-free medium in the presence or absence of 20 ng/mL GM-CSF or IO ng/mL tumor necrosis factor a (TNFa). After incubation, cells were collected and lysed in 120 pL of lysis buffer (25 mmol/ L glycylglycine, pH 7.8, 15 mmol/L MgSO,, 4 mmol/L EGTA, 1% Triton X-100, and 1 mmol/L D'lT). For TF-1, 10' cells were starved for 16 hours in serum-free medium without GM-CSF and then submitted to electroporation. Briefly, cells were resuspended in 400 pL of serum-free medium containing 10 pg of the fos reporter construct and 20 pg of carrier plasmid DNA. The mixture of cells and plasmid was allowed to stand at room temperature for 10 minutes before applying an electric shock of 250 V and 960 pF using a Genepulser (Bio-Rad, Hercules, CA). Five minutes after the pulse, cells were dispersed in 10 mL of serum-free media in the presence or absence of 200 pmol/L GM-CSF and then incubated at 37°C for 12 hours. TF-I cells were then collected and lysed as described for the for NIH-GMR transfectants.
Protein concentrations were determined by the method of Bradford (Bio-Rad) and adjusted for sample variation before dosage of luciferase activity in 100 pL of extracts as described:',@ RSV-GH (2 pg) was cotransfected as an internal control for transfection efficiency and growth hormone was determined using a radioimmunoassay kit (Immunocorp, Montreal, Quebec, Canada) according to the instructions provided by the manufacturer. In parallel, cells were transfected with RSV-luciferase as an external control and stimulated with GM-CSF as described.
Immunoprecipitations and Western blot analysis of JAK2 and STAT3. GM-CSF stimulated or control cells were washed once with PBS, solubilized at 4°C at a concentration of 2 X 10' cells/mL in phosphorylation solubilization buffer (PSB; ie, 50 mmol/L HEPES, pH 7.4, 100 mmol/L NaF, 10 mmol/L NaPPi, 2 mmol/L Na3V04, 4 mmol/L EDTA, 2 mmoIL phenylmethyl sulfonyl fluoride
[PMSF], 10 pg/mL leupeptin, and 2 pg/mL aprotinin) containing 0.5% NP-40. Extracts were then subjected to immunoprecipitation as previously described" with an antiphosphotyrosine monoclonal antibody (MoAb), 4G10 (Upstate Biotechnology, Lake Placid, NY) or with an anti-JAK-2 antibody (generously provided by Dr J. Ihle, St Jude Children's Research Hospital, Memphis, TN). After sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) using 7.5% polyacrylamide gels, proteins were electrophoretically transferred onto Immobilon polyvinylidene difluoride (PVDF) membranes (Millipore, Bedford, MA) using 500 mA for 90 minutes at 10°C in 25 mmol/L Tris, 192 mmoUL glycine, 0.05% SDS, and 20% methanol. Blots were blocked, incubated with an anti-JAK-2 antibody, 4G10, or with an anti-STAT3 (Transduction Laboratories, Lexington, KY) antibody and then with horseradish peroxidase-conjugated second antibody before adding ECL substrate solution and exposing to Kodak-Omat film (Eastman Kodak, Rochester, NY), as previously described." In some experiments, blots were stripped with 62.5 mmol/L. Tris-HCI, pH 6.8, 2% SDS, 100 mmol/L pmercaptoethanol at 50°C for 30 minutes, reblocked, washed, and reprobed.
Approximately lo7 NIH-GMR or TF-1 cells were serum-deprived overnight and either left untreated or stimulated with GM-CSF for 10 minutes at 37°C. The cultures were placed on ice, washed twice with icee-fos promoter-luciferase reporter assay.
Gel mobility shift analysis of SIE binding proteins.
cold PBS, and washed once with ice-cold hypotonic buffer. The cells were then lysed by the addition of 500 pL of hypotonic buffer containing 0.5% NP-40. The cell lysates were collected in Eppendorf tubes and agitated for 10 minutes at 4"C, and the nuclei were pelleted at 13,000g for 30 seconds. Cytosolic and high salt nuclear extracts were prepared as described" with minor modifications. Hypotonic buffer also contained 0.25 mmol/L sodium molybdate in addition to higher concentrations of leupeptin, aprotinin, pepstatin (3 pg/mL), and dithiothreitol (2 mmol/L). High salt buffer contained 400 mmol/ L NaCl instead of 420 mmolk. SIE DNA binding activity in the cytoplasnuc and nuclear extracts was determined by mobility shift assay with a "P-labeled high-affinity SIE oligonucleotide probe termed m67,'" as d e s~r i b e d . '~~~' Supershift experiments were performed with a mouse MoAb against STAT1 N-terminal region (Transduction Laboratories), an irrelevant mouse MoAb, 12CA5," and a rabbit polyclonal antiserum directed against the C-terminus of STAT3" or normal rabbit serum.
Subconfluent 60-mm petri dishes of NIH-GMR transfectants were washed once with PBS and incubated overnight in IMDM supplemented with I % BSA and 180 pg/mL Tf to render the cells quiescent. Cells were then stimulated with 800 pmol/ L GM-CSF for the indicated times at 37°C. Cell lysates were prepared and subjected to immunoprecipitation with a specific antiERKl serum" preadsorbed to protein A-Sepharose beads. The enzymatic activity of ERK-I was measured by immune complex assay using an MBP substrate as described p r e v i~u s l y .~~~~~ Protein kinase activities are expressed as picomoles of phosphate incorporated into MBP per minute per milligram of lysate proteins.
ERK activity assay.
RESULTS
GM-CSF-dependent cell proliferation and activation oj
c-fos promoter activity. In all NIH-GMR transfectants, GM-CSF could substitute in part for serum growth factors in supporting cell proliferation (Fig 1A and data not shown) . GM-CSF induced a dose-dependent stimulation of thymidine incorporation, with median effective concentrations of 30 to 50 pmoVL that were in the range of the dissociation constant of the GM-CSF receptor in these cells (40 to 100 pmol/L).
Previous studies indicate that GM-CSF induces c-fos mRNA accumulation and promoter activity, which are shown elsewhere to play a central role in integrating signalling networks evoked by a variety of extracellular stimuli. Thus, we tested in our transfectants the ability of GM-CSF to activate the murine c-fos promoter linked to the luciferase reporter gene. Our data indicate that GM-CSF induced a dose-dependent increase in c-fos promoter activity, which consistently reached a 10-to 18-fold increase at saturating concentrations of GM-CSF (Fig 1A) . More importantly, there was a twofold increase in c-fos promoter activity at 24 pmol/L of GM-CSF, which was also the biologically active threshold in the proliferation assay. At 120 pmoVL, the induction of c-fos was near maximal and correlated with a near maximal proliferative response to GM-CSF. Thus, there is a tight correlation between mitogenic response and activation of the c-fos promoter.
To directly address the contribution of c-fos in the response to GM-CSF, we overexpressed, in our NIH-GMR transfectants, a c-fos that lacks the DNA binding domain, Afos(139-145). This c-fos mutant, which has been shown to associate with c-jun but cannot bind to an AP-1 site, could act in a dominant negative manner on AP-I binding insert, pBABE-puro, were introduced into NIH-GMR cells by retroviral infection as described in the Materials and Methods. Two days after infection, cells were incubated in puromycin selection medium in the presence or absence of 800 pmol/L GM-CSF. After 6 days of culture in selective medium, cells were either submitted t o a viability count on the basis of trypan blue exclusion or submitted t o a thymidine incorporation assay as described in the Materials and Methods. Data shown are the mean of duplicate cultures.
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Afos( 139-145) was transduced into NIH-GMR cells using the pBABE-puro retroviral vector that confers resistance to puromycin. Because the abrogation of AP-1 function could be detrimental to the cells, the effects of Afos( 139-145) were assessed in a transient transduction assay in which GM-CSF stimulation was applied to the cells at the same time as the selective pressure. Control cultures were infected with a retrovirus harboring the vector without insert (Fig IB) . As determined by thymidine incorporation, GM-CSF induced a sixfold to sevenfold increase in cell proliferation in control cultures. However, in cells selected for expression of Afos( 139-143, no proliferative response to GM-CSF was observed. Together, our observations indicate that the presence of a functional AP-I complex is required for GM-CSF-dependent mitogenesis and suggest that GM-CSF-induced signalling events implicated in regulating c-fos transcription would be of biologic relevance.
Activation of both SIE and SRE sites of the clfos promoter by GM-CSF. To evaluate the contribution of STAT and SRF/TCF on c-fos promoter activation by GM-CSF, we used 
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> c-fos promoter constructs carrying inactivating mutations in either SIE or SRE or both (mSIE, mSRE, and mSIE-SRE, respectively). The specificities of the mSIE and mSRE mutations have been characterized previously.J".J' Figure 2 shows the structure of each mutant and their response to GM-CSF when linked to a luciferase reporter gene. Both total luciferase activity and fold induction by GM-CSF are shown for each construct. Wild-type c-fos promoter has a low but detectable activity in NIH-GMR cells maintained in serumfree medium. On stimulation with GM-CSF, there was a 15-fold induction for the wild-type fos construct (Fig 2) , whereas the activity of RSV promoter used as an external control was not significantly affected (data not shown). Interestingly, the basal level or GM-CSF-induced level of activity of mSIE was higher than that of mSRE, indicating that SRE has a greater contribution than SIE on intrinsic promoter activity. as reported by others. When the basal level of activity for each construct was taken as I , data shown in Fig  2 indicate that GM-CSF induced a sevenfold and ninefold increase in c-fos promoter activity for mSIE and mSRE. Fig 1) .
Fig 2. GM-CSF activates both the SRE and SIE sites of the fos promoter. The c-fos promoter constructs used are described in the Materials and Methods. NIH-GMR and TF-1 cells were transiently transfected with wild-type or mutated e-fos promoter linked to the luciferase reporter gene together with the RSV-GH control vector. After transfection, cells were incubated for 40 hours in serum-free medium in the presence (E) or absence (W) of 800 pmol/L GM-CSF. After incubation, the level of luciferase activity, in millivolts (mV), was measured as described in the Materials and Methods. Luciferase activity readings for TF-1 were comparable to those presented for duplicate cultures of NIH-GMR cells. For both NIH-GMR and TF-1 cells, data are expressed as the fold increase over control (as described in
respectively. Together, our observations are consistent with the view that both SRE and SIE can independently and additively mediate an increase in c-fos promoter activity in response to GM-CSF. The significance of both SIE and SRE contribution to c-fos activation was further investigated in TF-I cells, a bipotent erythroidmonocytic cell line that expresses CD34 and CD33 and requires GM-CSF for survival.3x Data observed with TF-1 are comparable to those observed with NIH-GMR and underscore the importance of both STATs and SRFRCF in c-fos promoter activation by GM-CSF (Fig 2) .
Activation of STAT proteins by GM-CSF. The tyrosine
kinase Jak2 is tyrosine phosphorylated and activated after GM-CSF stimulation in hematopoietic cell lines." In our transfectants, GM-CSF elicited a dose-dependent tyrosine phosphorylation of Jak-2 (Fig 3A) , indicating a conservation of GMR signalling events between hematopoietic and nonhematopoietic cells. It has been shown that Jak-2 activation in response to GM-CSF is followed by an activation of STAT5 in pro-B cells and monocyte^^^.^^ and more recently of STATl and 3 in neutr~phils.~'We therefore investigated the nature of STAT proteins activation on GM-CSF stimulation in NIH GMR and TF-1 cells. STAT3 is abundantly expressed in TF-I and NIH-GMR and become tyrosine phosphorylated in response to GM-CSF (Fig 3B) . As expected, STAT5 tyrosine phosphorylation was also detected in TF-I cells (data not shown). Because of the unexpected induction of STAT3 tyrosine phosphorylation by GM-CSF, the function of STAT3 was further investigated in gel shift assays.
Homodimeric and heterodimeric complexes of activated STAT1 and STAT3 bind with high affinity to oligonucleotide probes containing a synthetic STAT binding site termed m67.2'.s2 This site is derived from the SIE within the human c-fos gene promoter and forms three distinct mobility-shift complexes (SIF-A, -B, and -C) in cell extracts containing STATl and STAT3.2'.s* To assess the activation of these STATs by GMR ectopically expressed in NIH-3T3 cells or by endogenous GMR in TF-I cells, extracts from untreated or GM-CSF-treated cells were subjected to mobility shift assays with a "P-labeled m67 probe. We found that SIE DNA-binding activity was rapidly induced by GM-CSF in NIH-GMR cells (Fig 4, compare lanes 1 and 2) , in which all three SIF complexes (A, B, and C) were detected. These complexes clearly contained activated STATl and/or activated STAT3, because SIF-A and -B were specifically supershifted by the addition of STAT3 antiserum (Fig 4, compare  lanes 3 and 4) and SIF-B and SIF-C were specifically supershifted by the addition of STATl MoAb (Fig 4, compare  lanes 5 and 6) . The STAT3 antiserum was raised against the C-terminus of STAT3 and appears specific for STAT3." The STAT1 MoAb used specifically recognizes STATl (alp). It should also be noted that activation of both STAT1 and STAT3 was observed in all NIH-GMR transfectants tested (data not shown). In TFI cells, GM-CSF induces mainly For personal use only. on October 27, 2017. by guest www.bloodjournal.org From STAT3 homodimers (SIF-A) in a dose-dependent manner (Fig 5) . The concentrations of GM-CSF required for optimal activation of STAT1/3 more closely resemble those required for Jak-2 tyrosine phosphorylation than those required for cell proliferation or c-fos promoter activation. Significantly, the latter two events are determined after48 hours of stimulation, whereas the former are short-term events. The sum of these data clearly indicate a recruitment of both STAT1 and STAT3 on a c-fos SIE in response to GM-CSF in NIH-GMR and of STAT3 in TF-I cells. This activation of STAT3 and to a lesser extent of STAT1 could well account for the SIEdependent activation of c-fos promoter by GM-CSF shown in Fig 2. Role qf ERK-I in the SIE-and SRE-dependent activation of the c-fos promoter. Previous reports have shown a crucial role for ERK in Ras-dependent signalling. More recent studies indicate that ERK could also regulate STAT function, suggesting that STAT may be a target of both Jak and ERK." We therefore addressed the potential contribution of ERK activity in GM-CSF signalling and, more precisely, on the activation of the c-fos promoter. When ERK-1 activity was anti-Jak-2 IP A I GM-CSF (nM) . . Fig 3. GM-CSF induces the tyrosine phosphorylation of Jak-2 and STAT3. NIH-GMR andlor TF-1 cells were starved overnight in serumfree medium and then stimulated with GM-CSF for 10 minutes or left untreated. In (A), NIH-GMR cell extracts were subjected t o immunoprecipitation with anti-JAK-2, followed by SDS-PAGE and Western blotting with either an antiphosphotysine antibody (4G10) or an anti-JAK-2. In (6). cells were stimulated in 2 nmoI/L of GM-CSF.
Cell extracts were immunoprecipitated with an antiphosphotyrosine (4G101 followed by SDS-PAGE. Western analysis was performed on the immunoprecipitated extracts (anti-P-Tyr IP) or on total cell extracts (cell lysate) with an anti-STAT3. Activation of STATl and STAT3 by GM-CSF in NIH-GMR transfectants. NIH GMR cells were exposed t o GM-CSF (1 nmol/L) or control medium for 10 minutes at 37°C. Nuclear extracts (10 pg) were subjected t o electrophoretic mobility shift assay with a radiolabeled SIE probe as described in the Materials and Methods. The three specific GM-CSF-inducible complexes (SIF-A, -6, and -C) are indicated.
Parallel assays were performed with the GM-CSF-treated cell extracts, in which normal rabbit serum (NRS), STAT3 antiserum, an irrelevant mouse MoAb (12CA5). or STATl MoAb was added t o the binding reaction 30 minutes before the addition of probe. Antibody supershifting indicates that SlFA (A) is a STAT3 homodimer, SlFB (6) is a STAT1-STAT3 heterodimer, and SlFC (C) is a STATl homodimer.
directly measured by the MBP peptide phosphorylation assay, we observed a rapid and sustained increase in enzymatic activity (Fig 6) . This increased activity was detected within 5 minutes after GM-CSF stimulation, peaked at 15 minutes, and remained elevated for at least 3 hours. The activation of ERK-I was reproducibly detected in all clones tested (data not shown).
ERK-I phosphorylation at position 192 is crucial for its activation. It has been shown previously that a catalytically inactive ERK-I carrying a threonine to alanine mutation at position 192 can repress endogenous ERK activity and can inhibit growth factor-induced cell proliferation.'" We therefore used this dominant negative ERK to directly address the contribution of ERK activity on GM-CSF-induced cfos transcription. Hence, NIH-GMR cells were cotransfected in NIH GMR. NIH GMR or TF-1 were starved overnight and then exposed t o the indicated concentration of GM-CSF for 10 minutes at 37°C. Cytoplasmic extracts (10 pg) were subjected t o electrophoretic mobility shift assay with a radiolabeled SIE probe as described in the Materials and Methods. The composition of the A, B, and C complexes is described in Fig 4. with c-fos luciferase reporter constructs and with the mutant ERKl92A cloned in the pRC-CMV expression vector. Control cells were cotransfected with the expression vector without insert (Fig 7) . The presence of ERK192A resulted in a 50% decrease in wild-type c-fos promoter induction by GM-CSF. An inhibition of the same order of magnitude was also observed for mSIE and mSRE constructs. Cells stimulated with TNFa were used as controls, because TNFa is known to be a weak activator of MAPK"' and was shown to preferentially activate the ERK-related JNK kinase.>* Thus, TNFa promoted cell proliferation and c-fos promoter activity in our transfectants without affecting ERK activity (Table I) . As shown in Fig 7, expression of the dominant negative ERK192A did not interfere with TNFa-induced c-fos promoter activity, indicating the specificity of inhibition observed with GM-CSF. Taken together, these data suggest that ERKl regulates c-fos transcription induced by GM-CSF through both STAT1/3 and SRF/TCF complexes.
DISCUSSION
The experiments described above suggest that the regulation of c-fos is important for GM-CSF-dependent signalling and examine the mechanisms whereby ligand-dependent activation of the GM-CSF receptor leads to an increase in cfos promoter activity. Our data provide direct evidence for a contribution of both STAT1/3 and SRF/TCF to c-fos pro- For personal use only. on October 27, 2017. by guest www.bloodjournal.org From and long-term cellular responses,59 we chose to study the molecular basis of GM-CSF-induced cellular responses using c-fos as an indicator. We first sought to address the importance of c-fos in GM-CSF-induced cell proliferation. Our experiments indicate a tight correlation between induction of cell proliferation by GM-CSF and activation of the c-fos promoter. Furthermore, overexpression in NIH-GMR transfectants of a trans-dominant c-fos mutant allowed us to directly address the contribution of AP-1 function in response to GM-CSF. To measure the effects of the Afos mutant, we used a transient dual-selection proliferation assay. Thus, Afos was transduced into the cells through retroviral infection that allows for reproducible and high efficiency gene transfer and permits a direct comparison with cells receiving the selective marker alone. Furthermore, infected cells (with Afos or control vector) were selected simultaneously for puromycin resistance and for proliferative response to GM-CSF in serum-free medium. Under these conditions, cells need both puromycin resistance and a positive response to GM-CSF to survive and proliferate. Hence, this transient selection-proliferation assay may be applicable to the study of genes that irreversibly affect essential cell functions.
It was previously believed that SRE is necessary and sufficient to confer serum response to the c-fos promoter. The contribution of SIE was shown by PDGF stimulation, but was thought to be weak. To quantitate the contribution of either cis-regulating element to the activation of the c-fos promoter by GM-CSF, we chose to use luciferase as a reporter gene for its sensitivity of detection and linearity over a broader range of activity. Thus, the sensitivity of the assay has allowed us to define the important contribution of both SIE and SRE to the GM-CSF response of the c-fos promoter, although SRE appears to be dominant over SIE on intrinsic promoter activity. Interestingly, mutation of S E consistently results in a threefold to fourfold increase in basal fos promoter activity in unstimulated cells. It is possible that the activity of the c-fos promoter is repressed by factors that are constitutively bound to sequences that are adjacent to SIE, hence the dominance of SRE over SIE on intrinsic promoter activity observed here and Mutation or deletion of these sites may provide a direct answer to this question. Despite this constitutive repression, a fos promoter construct that can no longer recruit SRF/TCF is reproducibly induced fourfold to ninefold by GM-CSF, indicating the importance of STAT3 and possibly STATl on c-fos promoter activity in response to GM-CSF. Although we have not directly addressed the contribution of other binding sites that have been identified in the c-fos promoter, such as the AP-I -like FAP site and the CdCRE, our data indicate an essential role for SIE and SRE in mediating the GM-CSF-dependent activation of c-fos promoter because a construct bearing mutations at both these sites is unresponsive to GM-CSF stimulation. In contrast to previous results, the contributrion of both SJE and SRE in our cells more closely resembles the recent observations reported by Hill and Trekmadl in vitro, as well as the in vivo requirement for all of the regulatory elements of the c-fos promoter in the response evoked by extracellular stimuli in transgenic mice carrying fos promoter-LacZ fusions.6* The authors suggest that this cooperativity could be attributed to the formation, by the transcription factors, of a nucleation site that directs the assembly of an interdependent transcription complex on chromosomal DNA.
The GM-CSF-inducible complexes that form on a highaffinity SIE probe migrated at the same position as SIF-A, -B, and -C, indicating the formation of STATU3 homodimers and heterodimers, which were confirmed by supershifting with specific anti-STAT1 and anti-STAT3, respectively. In monocytes and pro-B cells, GM-CSF was previously shown to activate STAT5 and not STATl and STAT3.24,55,63 However, in murine fibroblasts, our data suggest that GMR can activate both STATl and STAT3. Surprisingly, in the CD34' cell line TF-1, GM-CSF also activates STAT3. Thus, our data are consistent with the view that the recruitment of STAT family members may be more promiscuous than previously anticipated, although we have not ruled out the possibility that it may also depend on the affinity of the receptor for specific STAT proteins. Interestingly, the disruption of STATl gene did not ilffect normal development, but the mice were highly susceptible to viral infection, possibly due to their unresponsiveness to IFN."z65 The response to other cytokines that include GH, EGF, or IL-10 was nonetheless unaffected, suggesting a functional redundance of STAT1 with STAT3 in these pathways. In TF-1 cells, our data clearly suggest that STAT3 rather than STATl is activated by GM-CSF. Mutations of SIE results in a 50% decrease in GM-CSF-induced c-fos promoter activity, indicating a direct link between STAT activation by GMR and c-fos transcription in both NIH-GMR and TF-1 cells. Further addressing the importance of STAT3 and STAT5 in signal transduction will require gene ablation in transgenic mice or the use of a dominant negative STAT mutant.
Previous studies have independently shown that GM-CSF induces the tyrosine phosphorylation of p42MAPK and p44MAPK in hematopoietic cells and in GMR-transfected fibroblasts and also activates MAPK in human neutrop h i l~. " ,~,~' Two lines of evidence suggest an important role for the MAPK pathway in GM-CSF signalling. Overexpression of SHC was shown to increase the response of TF-1 cells to GM-CSF,68 whereas a truncated GMR that can no longer recruit Ras does not suppress apoptosis in transfected BaF3 cells.' These data argued for an important role for the STAT-and SRF/TCF-mediated c-fos promoter activity and that regulation of STAT activity is not attributed solely to tyrosine phosphorylation by Jak kinases, but also to ERK mediated serine phosphorylatiod6 (Fig 8) . In summary, our data are consistent with the view that the Jak-STAT and ras-MAPK-TCFISRF pathways can independently and cooperatively contribute to c-fos transcription after ligand-induced activation of GMR. Furthermore, the activation of MAPK may provide the possibility of pathway cross-talk and fine turning of the response evoked by GM-CSF.
